N/A
N=11
Flexibility and Strength Training in Asthma
Asthma
Bottom Line
View on ClinicalTrials.gov: NCT02370004 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcome: Primary: Forced Expiratory Volume at One Second - FEV1 % Predicted — 91.4; 93.4 % predicted — p=.10
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Resistive Flexibility and Strength Training (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Brigham and Women's Hospital
- Primary completion
- Apr 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Forced Expiratory Volume at One Second - FEV1 % Predicted |
91.4; 93.4 | .10 |
| SECONDARY Asthma Control Test (ACT) |
19.2; 21.2 | — |
| SECONDARY Range of Motion Measurement- Circumference |
93.1; 95.4; 88.9; 90.4; 78.7; 82.4 | — |
| SECONDARY Range of Motion Measurements- Degree of Motion |
8.5; 8.5; 9.6; 8.1; 37.6; 38.7 | — |
Summary
The aim of the study is proof of concept and to establish the feasibility of performing a study of resistive flexibility and strength training (RFST) in patients with asthma, with the future goal of designing a larger randomized trial to test the hypothesis that RFST leads to greater improvement in asthma symptoms, pulmonary function tests, range of motion and connective tissue mobility compared with a control conventional physical therapy intervention.
Eligibility Criteria
Inclusion Criteria
- Male and female patients, age ≥ 18 yrs
- Physician-diagnosed asthma
- Currently taking asthma medications
- Asthma Control Questionnaire (ACQ) score >1.25
Exclusion Criteria
- Smoking history of ≥10 pack years
- Pregnancy or lactation or subjects planning to get pregnant during the course of the trial
- Major medical problems prohibiting study participation, i.e. presence of chronic or active lung disease other than asthma or history of unstable significant medical illness other than asthma or concurrent medical problems that would place the participant at increased risk as determined by the study physician
Data sourced from ClinicalTrials.gov (NCT02370004). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.